Mettl3-mediated m6A RNA methylation regulates the fate of bone marrow mesenchymal stem cells and osteoporosis
mRNA modifications have been shown to regulate mammalian development and disease. Here the authors show that the m6A methyltransferase Mettl3 ensures translational efficiency of the mesenchymal stem cell lineage allocator Pth1r, promoting osteogenesis and protecting from osteoporosis.
Guardado en:
Autores principales: | Yunshu Wu, Liang Xie, Mengyuan Wang, Qiuchan Xiong, Yuchen Guo, Yu Liang, Jing Li, Rui Sheng, Peng Deng, Yuan Wang, Rixin Zheng, Yizhou Jiang, Ling Ye, Qianming Chen, Xuedong Zhou, Shuibin Lin, Quan Yuan |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6dee164452b4421384ea332c5f24434f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Alpha-ketoglutarate ameliorates age-related osteoporosis via regulating histone methylations
por: Yuan Wang, et al.
Publicado: (2020) -
The miR-4739/DLX3 Axis Modulates Bone Marrow-Derived Mesenchymal Stem Cell (BMSC) Osteogenesis Affecting Osteoporosis Progression
por: Ding Li, et al.
Publicado: (2021) -
In Osteoporosis, differentiation of mesenchymal stem cells (MSCs) improves bone marrow adipogenesis
por: Pino,Ana María, et al.
Publicado: (2012) -
Mettl3-mediated mRNA m6A methylation promotes dendritic cell activation
por: Huamin Wang, et al.
Publicado: (2019) -
Prognostic role of METTL1 in glioma
por: Lun Li, et al.
Publicado: (2021)